Citigroup Inc Collegium Pharmaceutical, Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Citigroup Inc holds 50,070 shares of COLL stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,070

Previous 31,854 57.19%

Holding current value

$1.67 Million

Previous $1.03 Million 88.68%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $571,982 - $711,699	18,216 Added 57.19%	50,070 $1.93 Million
Q2 2024 Aug 12, 2024	SELL	$31.36 - $39.99 $603,648 - $769,767	-19,249 Reduced 37.67%	31,854 $1.03 Million
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $801,205 - $1.05 Million	25,655 Added 100.81%	51,103 $1.98 Million
Q4 2023 Feb 09, 2024	BUY	$21.16 - $30.8 $187,752 - $273,288	8,873 Added 53.53%	25,448 $783,000
Q3 2023 Nov 09, 2023	SELL	$21.23 - $24.28 $352,885 - $403,582	-16,622 Reduced 50.07%	16,575 $370,000
Q2 2023 Aug 10, 2023	BUY	$21.06 - $24.0 $297,535 - $339,072	14,128 Added 74.09%	33,197 $713,000
Q1 2023 May 11, 2023	SELL	$23.0 - $29.88 $75,187 - $97,677	-3,269 Reduced 14.63%	19,069 $457,000
Q4 2022 Feb 09, 2023	SELL	$16.14 - $23.55 $101,891 - $148,671	-6,313 Reduced 22.03%	22,338 $518,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $17,392 - $22,612	1,125 Added 4.09%	28,651 $459,000
Q2 2022 Aug 10, 2022	SELL	$14.22 - $20.88 $225,458 - $331,052	-15,855 Reduced 36.55%	27,526 $488,000
Q1 2022 May 12, 2022	BUY	$17.2 - $22.5 $73,822 - $96,570	4,292 Added 10.98%	43,381 $883,000
Q4 2021 Feb 10, 2022	BUY	$17.5 - $21.35 $140,700 - $171,654	8,040 Added 25.89%	39,089 $730,000
Q3 2021 Nov 10, 2021	BUY	$17.75 - $25.39 $551,119 - $788,334	31,049 New	31,049 $613,000

Others Institutions Holding COLL

# of Institutions

253

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.14B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account